Unknown

Dataset Information

0

Polymeric Carriers for Delivery Systems in the Treatment of Chronic Periodontal Disease.


ABSTRACT: Periodontitis (PD) is a chronic inflammatory disease of periodontal tissues caused by pathogenic microorganisms and characterized by disruption of the tooth-supporting structures. Conventional drug administration pathways in periodontal disease treatment have many drawbacks such as poor biodistribution, low selectivity of the therapeutic effect, burst release of the drug, and damage to healthy cells. To overcome this limitation, controlled drug delivery systems have been developed as a potential method to address oral infectious disease ailments. The use of drug delivery devices proves to be an excellent auxiliary method in improving the quality and effectiveness in periodontitis treatment, which includes inaccessible periodontal pockets. This review explores the current state of knowledge regarding the applications of various polymer-based delivery systems such as hydrogels, liposomes, micro-, and nanoparticles in the treatment of chronic periodontal disease. Furthermore, to present a more comprehensive understanding of the difficulties concerning the treatment of PD, a brief description of the mechanism and development of the disease is outlined.

SUBMITTER: Zieba M 

PROVIDER: S-EPMC7407295 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Polymeric Carriers for Delivery Systems in the Treatment of Chronic Periodontal Disease.

Zięba Magdalena M   Chaber Paweł P   Duale Khadar K   Martinka Maksymiak Magdalena M   Basczok Maciej M   Kowalczuk Marek M   Adamus Grazyna G  

Polymers 20200715 7


Periodontitis (PD) is a chronic inflammatory disease of periodontal tissues caused by pathogenic microorganisms and characterized by disruption of the tooth-supporting structures. Conventional drug administration pathways in periodontal disease treatment have many drawbacks such as poor biodistribution, low selectivity of the therapeutic effect, burst release of the drug, and damage to healthy cells. To overcome this limitation, controlled drug delivery systems have been developed as a potential  ...[more]

Similar Datasets

| S-EPMC9031663 | biostudies-literature
| S-EPMC4674818 | biostudies-other
| S-EPMC7238125 | biostudies-literature
| S-EPMC6296687 | biostudies-other
| S-EPMC7077204 | biostudies-literature
| S-EPMC5877609 | biostudies-literature
| S-EPMC10056703 | biostudies-literature
| S-EPMC6389875 | biostudies-literature
| S-EPMC6158909 | biostudies-literature
| S-EPMC5098795 | biostudies-literature